ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,822Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 680

$1.22M Total Retail Price of All Prescriptions

Rank: 43 out of 680

653 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 653 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

26% of this provider’s 653 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 13,249 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 635 434 S3 1 4
AMLODIPINE BESYLATE 599 515 2 1
SIMVASTATIN 570 407 3 3
NEXIUM 496 339 4 16
FUROSEMIDE 459 373 5 6
LISINOPRIL 413 259 6 5
GABAPENTIN 392 218 7 15
OMEPRAZOLE 383 280 8 7
METOPROLOL TARTRATE 374 250 9 12
ATORVASTATIN CALCIUM 332 236 10 11
POTASSIUM CHLORIDE 302 254 11 14
CLONIDINE HCL 301 237 12 36
METFORMIN HCL 278 186 13 8
ATENOLOL 272 151 14 19
LEVOTHYROXINE SODIUM 270 198 15 2
METOPROLOL SUCCINATE 268 239 16 13
WARFARIN SODIUM 248 210 17 20
VENLAFAXINE HCL ER 242 153 18 101
DIOVAN 239 188 19 31
ZOLPIDEM TARTRATE 239 164 19 17
PANTOPRAZOLE SODIUM 235 179 21 30
CLOPIDOGREL 216 184 22 26
CARVEDILOL 209 149 23 23
CYMBALTA 187 75 24 46
JANUVIA 176 131 25 60
MELOXICAM 159 119 26 24
PLAVIX 158 122 27 39
GLIPIZIDE 155 116 28 63
METOCLOPRAMIDE HCL 154 125 29 118
HYDROCHLOROTHIAZIDE 143 94 30 9
RANITIDINE HCL 139 111 31 56
RAMIPRIL 135 119 32 69
TIZANIDINE HCL 126 50 33 140
TRAZODONE HCL 124 67 34 48
NABUMETONE 112 65 35 174
CYCLOBENZAPRINE HCL 110 58 R 36 81
HYDRALAZINE HCL 109 83 37 71
PRAVASTATIN SODIUM 109 85 37 10
DONEPEZIL HCL 108 94 39 27
CRESTOR 107 88 40 25
ALPRAZOLAM 106 69 41 72
CIPROFLOXACIN HCL 102 59 42 57
GEMFIBROZIL 101 67 43 106
DIGOXIN 96 58 44 58
COMBIVENT 95 52 45 168
ALENDRONATE SODIUM 95 78 45 32
PROMETHAZINE HCL 95 56 R 45 96
QUETIAPINE FUMARATE 93 47 48 64
LOSARTAN POTASSIUM 90 83 49 21
PROAIR HFA 90 58 49 67
PREMARIN 89 68 R 51 105
ENABLEX 88 68 52 217
CELEBREX 88 42 52 90
PREDNISONE 87 58 54 50
ADVAIR DISKUS 86 53 55 53
LIPITOR 85 58 56 68
AGGRENOX 83 74 57 177
CARISOPRODOL 81 44 R 58 83
BYSTOLIC 79 57 59 79
DEXILANT 78 64 60 171
ROPINIROLE HCL 75 58 61 99
SPIRIVA 73 48 62 70
BENAZEPRIL HCL 73 43 62 40
TRAMADOL HCL 73 57 62 18
SPIRONOLACTONE 72 45 65 82
LYRICA 71 43 66 77
SERTRALINE HCL 70 57 67 28
CILOSTAZOL 70 55 67 230
PAROXETINE HCL 69 29 69 76
TRICOR 68 48 70 98
ALLOPURINOL 67 53 71 33
LACTULOSE 67 52 71 92
KLOR-CON M20 64 18 73 61
MEGESTROL ACETATE 63 56 R 74 88
ESTROPIPATE 61 25 R 75 381
METHYLPREDNISOLONE 61 36 75 93
MIRTAZAPINE 60 53 77 78
LEVETIRACETAM 59 50 78 120
ISOSORBIDE MONONITRATE ER 59 53 78 59
LANTUS SOLOSTAR 58 40 80 84
ESCITALOPRAM OXALATE 56 46 81 45
MECLIZINE HCL 56 48 81 103
FLUOXETINE HCL 56 31 81 74
BUMETANIDE 56 48 81 102
POLYETHYLENE GLYCOL 3350 55 40 85 62
CITALOPRAM HBR 55 40 85 22
ISOSORBIDE DINITRATE 54 48 87 227
DETROL LA 54 32 87 169
TAMSULOSIN HCL 54 51 87 34
IBUPROFEN 53 24 90 126
CARBIDOPA-LEVODOPA 52 52 91 117
TOPIRAMATE 52 18 91 233
NAMENDA 52 52 91 35
VENTOLIN HFA 51 24 94 202
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.